Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Current Assets
Cash	$ 3,227,634	$ 3,026,569
Advances on research and development contract services	328,844	328,844
Prepaid insurance	273,096	372,350
Prepaid expenses	10,000	10,000
Total current assets	3,839,574	3,737,763
Total assets	3,839,574	3,737,763
Current Liabilities
Accounts payable and accrued expenses	146,186	360,662
Accrued legal settlement		414,989
Warrant liability	18,440	55,751
Total current liabilities	164,626	831,402
Total liabilities	164,626	831,402
Commitments and Contingencies
Stockholders’ Equity
Preferred Stock, $0.001 par value per share; 20,000,000 shares authorized; none issued or outstanding at March 31, 2024 and December 31, 2023
Common stock, $0.001 par value per share; 100,000,000 shares authorized; 1,016,489 and 534,238 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively	1,016	534
Additional paid-in capital	85,448,860	83,814,785
Accumulated deficit	(81,774,928)	(80,908,958)
Total stockholders’ equity	3,674,948	2,906,361
Total liabilities and stockholders’ equity	$ 3,839,574	$ 3,737,763